查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094838

獸醫即時診斷市場－全球市場預測（2026-2032年）

Veterinary Point Of Care Diagnostics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫即時診斷市場將成長至 51.3 億美元，複合年成長率為 12.87%。

主要市場統計數據
基準年 2025 21.9億美元
預計年份：2026年 24.7億美元
預測年份 2032 51.3億美元
複合年成長率 (%) 12.87%

獸醫即時診斷是指在診所、農場、動物收容所、馬匹飼養設施和移動獸醫服務場所進行的快速、現場檢測，旨在為伴侶動物和牲畜提供及時的臨床決策支援。此類別包括免疫檢測、血液學和臨床化學分析儀、分子檢測、尿液檢查、血氣和電解質測量系統、寄生蟲篩檢、傳染病檢查以及新興的互聯診斷平台。寵物飼養量的增加、人們對動物保健期望的提高、對通用感染疾病和食源性疾病的認知不斷增強，以及分散式醫療環境中對快速治療決策的需求，都推動了即時診斷的發展。在伴侶動物保健方面，即時診斷可以幫助獸醫在一次就診中評估急性疾病、後續觀察慢性疾病、確定抗生素的使用，並改善與飼主的溝通。在牲畜和生產動物的健康管理方面，快速診斷有助於畜群管理、生物安全、感染疾病控制和合理用藥。此外，隨著動物疫病監測與公共衛生、食品安全和抗菌素抗藥性控制的關聯日益緊密，「同一健康」概念也正在影響獸醫診斷的發展趨勢。獸醫實踐對檢測結果速度、診斷可靠性和工作流程效率的要求不斷提高，使得獸醫即時診斷成為支撐整個動物健康系統預防保健、精準治療和運作韌性的關鍵要素。

一項變革性的變革，將重塑獸醫診斷的進行方式。

獸醫即時診斷領域正經歷著一場變革，其驅動力來自數位連接、儀器小型化、分子檢測以及更廣泛的預防性醫療保健模式的融合。獸醫醫院正從被動檢測轉向疾病早期發現、常規健康篩檢以及腎臟病、內分泌失調、發炎性疾病和感染疾病等慢性疾病的長期監測。攜帶式分析儀和試劑盒系統減少了在時間緊迫的決策過程中對中心實驗室的依賴，而雲端連接平台則改善了記錄整合、品管和檢測結果的獲取。在畜牧業健康管理中，快速檢測對於農場層面的生物安全、育種管理、呼吸道疾病控制、乳房炎篩檢和跨境動物疫病監測的重要性日益凸顯。此外，隨著監管和公共衛生部門越來越重視合理使用抗生素，能夠在開始治療前區分細菌、病毒、寄生蟲和發炎性疾病病因的診斷技術的價值也日益成長。同時，獸醫團隊正面臨人員短缺和病例日益複雜化的雙重困境，這使得方便用戶使用、自動化程度高且維護成本低的診斷系統顯得尤為重要。其中最顯著的結構性變化是整合式診斷生態系統的轉變，該生態系統融合了即時檢測、電子健康記錄、遠端醫療支援和數據驅動的臨床決策。

人工智慧對獸醫診斷的累積影響

人工智慧 (AI) 透過改善觀察解讀、自動化工作流程、影像識別、預測分析和臨床決策支持，對獸醫即時診斷整體累積的影響。 AI 驅動的診斷工具可支援細胞學、血液學、尿液分析、放射學和數位顯微鏡等工作流程中的模式識別，幫助獸醫專業人員更有效地篩選異常觀察。在即時診療環境中，AI 可以減少人工解讀的差異，識別品管問題，並幫助臨床醫生將檢測結果與患者病歷、品種、年齡、臨床症狀和治療反應聯繫起來。機器學習模型也被探索用於早期檢測動物群體中的疾病模式，例如集體爆發層面的健康監測、疫情爆發徵兆和抗生素抗藥性趨勢。這項技術在獸醫專業知識分佈不均的地區尤其有用，因為 AI 平台可以將決策支援擴展到當地診所、農場、收容所和行動診療單元。然而，人工智慧的實施需要檢驗的資料集、透明的演算法、網路安全措施、監管細則以及臨床醫生的監督。人工智慧最實際的短期作用並非取代獸醫的判斷，而是加快並提高對常規觀察解讀的一致性，加強監測系統，並實現更積極主動的動物健康管理。

獸醫即時診斷的關鍵區域見解

在亞太地區，隨著伴侶動物診所、家禽和生豬養殖場、酪農企業以及水產養殖健康管理計畫中獸醫即時診斷的重要性日益凸顯，該地區正經歷著快速發展。都市區寵物飼養的普及、獸醫基礎設施的不斷完善以及政府對動物疾病監測的重視，正在推動中國、印度、日本、韓國和澳洲等國採用該技術。同時，由於該地區牲畜密度高，感染疾病監測和農場層面的檢測仍然是公共衛生和食品安全的核心優先事項。在北美，臨床應用已進入成熟階段，這得益於大規模的伴侶動物醫療保健基礎設施、先進的獸醫醫院網路、某些地區寵物保險的普及以及人們對合理使用抗生素和慢性病監測的濃厚興趣。拉丁美洲的需求模式呈現兩種特徵：一是都市區伴侶動物照護的擴展；二是牛、家禽和生豬生產系統中對牲畜診斷（尤其是快速檢測）的持續需求，以支持出口法規的遵守、畜群健康管理和通用感染疾病控制。在歐洲，對規範的動物健康實踐、食品安全、動物福利標準以及減少抗菌藥物使用的政策的重視，正在增強臨床和生產環境中基於診斷的治療決策的合法性。在中東，透過對高階寵物護理、馬匹醫療、與獵鷹相關的獸醫服務以及食品安全和牲畜疾病控制的投資，診斷技術的應用正在逐步推進。在非洲，預計將出現基於需求的巨大機會。即時檢測可以支持通用感染疾病監測，提高牲畜生產力，並為農村地區提供獸醫服務，但基礎設施不足、成本限制和供應鏈穩定性等挑戰仍然是其推廣應用的主要障礙。

影響獸醫診斷技術應用的關鍵群體特定見解

受都市區寵物護理支出成長、家禽和水產養殖業擴張以及跨境動物疾病日益成長的擔憂所驅動，東協市場對用於獸醫和現場的快速便捷診斷技術的需求日益成長。在海灣合作理事會（GCC）國家，高價值伴侶動物服務、馬匹和駱駝健康管理以及國家糧食安全計畫對加強牲畜健康監測和生物安全能力的需求也在擴大。歐盟為獸醫即時診斷提供了政策主導環境之一，其動物福利法規、食品安全系統和抗菌素抗藥性措施促進了循證處方和系統性疾病監測。金磚國家（BRICS）的診斷需求多樣但至關重要，涵蓋了從大規模的伴侶動物群體和不斷擴張的私人獸醫診所到需要經濟高效的感染疾病檢測和全群健康管理的集約化畜牧系統。七國集團（G7）市場通常為技術應用提供了有利環境，擁有完善的獸醫基礎設施、診所內檢測的高接受度、電子健康記錄的廣泛使用以及對預防醫學的高度重視。雖然北約成員國不是獸醫市場集團，但它們包括許多擁有先進獸醫公共衛生系統、國防相關動物衛生計劃和生物安全優先事項的國家，這凸顯了快速診斷在感染疾病疫情防範、工作動物健康管理和跨境疾病監測中的重要性。

影響獸醫照護現場診斷的主要國家趨勢

美國仍然是獸醫照護現場技術的領先應用國，這得益於其廣泛的伴侶動物護理網路、強大的專科和急診獸醫服務，以及人們對預防性篩檢和慢性病監測日益成長的興趣。加拿大對伴侶動物照護、牲畜健康管理和合理使用抗生素的需求穩定，都市區診所、酪農和偏遠地區的獸醫服務需求各不相同。在墨西哥，寵物照護服務的擴張以及對牲畜疾病管理（尤其是在牛、家禽和豬養殖方面）的需求正在影響著市場。巴西擁有世界領先的畜牧業，並且對伴侶動物醫療的期望不斷提高，因此快速診斷技術在提高農場生產力和最佳化都市區動物醫院的工作流程方面發揮著至關重要的作用。在英國，對伴侶動物健康、馬匹護理、檢查室級別的臨床標準以及合理使用抗生素的重視，都為基於診斷的獸醫決策提供了支持。德國受益於先進的獸醫基礎設施、健全的畜牧生產標準和嚴格的動物健康監管，而法國則在伴侶動物醫學、肉類動物健康以及國家監測系統等各個領域都存在需求。俄羅斯獸醫實踐的需求受制於廣大的地域、畜牧業生產以及在檢測設施匱乏地區分散式檢查的重要性。在義大利和西班牙，成熟的小型動物診療模式、畜牧系統以及對感染疾病控制（包括溫帶地區的媒介傳播疾病和寄生蟲病）的重視，都支撐著這些需求。在中國，隨著寵物醫學的發展、獸醫服務的現代化以及大規模畜牧和水產養殖的疾病管理，診斷技術的應用正在不斷擴展。在印度，乳牛、家禽、伴侶動物和農村獸醫服務領域迫切需要價格合理且便攜的診斷技術。日本在伴侶動物醫學和老年寵物照護方面展現了高標準，尤其注重支持慢性病管理和快速臨床決策的診斷方法。澳洲高度重視生物安全、牲畜健康、馬匹醫療、伴侶動物照護以及在地理分散地區進行的疾病監測。韓國則受益於寵物數量的成長、先進的都市區獸醫診所以及院內診斷技術的廣泛應用。

為獸醫診斷領域的領導者提供的實用建議

產業領導者應優先考慮兼具準確性、速度、易用性和連接性的診斷平台，同時確保其能夠融入獸醫團隊的實際工作流程。產品策略應著重於緊湊型分析儀、多參數檢測、簡單的樣本製備、清晰的結果解讀以及與臨床管理系統的整合。在伴侶動物照護領域，領導者應使其產品線與健康檢查、緊急分診、慢性病監測、感染疾病譜檢測以及能夠提高治療接受度的寵物飼主溝通工具相契合。在畜牧業和田間環境中，應重點關注產品的便攜性、低維護成本、耐高溫耗材以及能夠支持生物安全、畜群健康管理和合理使用抗生素的成本效益型檢測。銷售團隊應根據不同地區調整其市場進入模式。具體而言，他們應認知到，在高所得的都市區診所，高連接性和廣泛的檢測範圍可能更為重要；而在農村地區和生產基地，價格實惠、耐用性和培訓支援可能更為重要。循證實踐至關重要。供應商應投資於臨床檢驗、物種特異性表現數據、品管方案和培訓，以幫助獸醫負責任地解讀結果。與獸醫學院、公共衛生機構、畜牧組織、動物收容所和數位醫療服務提供者夥伴關係，可以加速負責任地應用這些技術。此外，領導者還需要透過加強資料管治、網路安全、演算法檢驗和透明的臨床決策支援框架，為人工智慧驅動的診斷做好準備。

獸醫即時診斷分析的調查方法

本執行摘要採用系統性的二手研究方法撰寫而成，重點關注來自動物衛生機構、獸醫協會、同行評審文獻、監管資訊來源、公共衛生機構、學術出版物和權威政府數據檢驗的經驗證且有數據支持的行業證據。此調查方法評估了伴侶動物照護、牲畜健康、通用感染疾病監測、合理使用抗菌藥物、獸醫專業發展趨勢以及診斷技術應用等領域的需求研究途徑。透過檢驗獸醫基礎設施的成熟度、動物族群動態、與畜牧生產的相關性、生物安全優先事項、寵物醫療保健趨勢、法規環境以及診斷服務的可及性，評估了區域、群體和國家層面的具體情況。該研究框架強調定性檢驗而非市場規模估算和預測，確保分析牢固地建立在觀察到的行業趨勢和已記錄的醫療保健需求之上。技術趨勢涵蓋免疫診斷、臨床化學、血液學、分子診斷、數位顯微鏡、連網分析儀和人工智慧驅動的結果解讀等領域。研究結果被整合起來，揭示了其對獸醫醫院、動物保健服務提供者、診斷設備開發商、畜牧業相關人員和公共衛生決策者的實際意義。所有結論均以支持策略規劃的方式呈現，不依賴推測性的市場估算和預測、市場佔有率計算或基於未來展望的收入預測。

結論：即時診斷在獸醫學中的策略作用

隨著獸醫、畜牧相關人員和公共衛生利益相關人員對更快、更可靠、更便捷的診斷結果的需求日益成長，即時診斷在獸醫學領域正成為現代動物保健的重要組成部分。預防醫學、合理使用抗生素、通用感染疾病監測、慢性病監測以及獸醫工作流程現代化等趨勢正在推動這一領域的發展。儘管不同地區的部署情況會因獸醫基礎設施、動物健康優先事項、經濟負擔、法規和生物安全需求而有所不同，但其基本方向始終如一：快速的院內和現場診斷正日益成為臨床和集體決策的核心。人工智慧、互聯互通和自動化技術，如果經過適當的檢驗和獸醫監督，可以提高診斷的一致性和工作流程效率。對於行業領導者而言，最具永續的機會在於開發經臨床檢驗、方便用戶使用、可連網且能夠適應不同環境的解決方案，從而同時支援伴侶動物保健和生產動物健康。透過將創新與獸醫護理的實際情況相結合，即時診斷可以改善治療決策，加強監測，減少不適當抗生素的使用，並提高全球市場的動物福利。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸醫即時診斷市場：依產品類型分類

  • 儀器和分析設備
  • 耗材和試劑
  • 快速檢測套組

第8章 獸醫即時診斷市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 馬
    • 家禽
    • 豬

第9章 獸醫即時診斷市場：依診斷測試類型分類

  • 臨床生物化學
  • 血液學
  • 免疫診斷
  • 分子診斷
  • 尿液檢查

第10章 獸醫即時診斷市場：依技術分類

  • ELISA
  • 橫向流動化驗
  • PCR
  • 微流體技術

第11章 獸醫即時診斷市場：依樣本類型分類

  • 血
  • 屎
  • 牛奶
  • 唾液
  • 尿

第12章 獸醫即時診斷市場：依應用領域分類

  • 傳染病檢查
  • 臨床病理
  • 內分泌學
  • 寄生蟲學
  • 代謝性疾病

第13章 獸醫即時診斷市場：依最終用戶分類

  • 獸醫醫院和診所
  • 獸醫診斷檢查室
  • 研究機構
  • 畜牧場及設施

第14章 獸醫即時診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 獸醫即時診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 獸醫即時診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Agrolabo Spa
  • Antech Diagnostics, Inc. by Mars, Incorporated
  • B. Braun SE
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Dispomed Ltd.
  • Esaote SpA
  • Eurolyser Diagnostica GmbH
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Getein Biotech, Inc.
  • IDEXX Laboratories, Inc.
  • Medtronic PLC
  • Mindray Medical International Limited
  • Neogen Corporation
  • Nova Biomedical Corporation
  • Precision Biosensor Inc.
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac Corporation
  • Woodley Equipment Company Inc.
  • Zoetis Inc.
Product Code: MRR-3A2E844FD625

The Veterinary Point Of Care Diagnostics Market is projected to grow by USD 5.13 billion at a CAGR of 12.87% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.19 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 5.13 billion
CAGR (%) 12.87%

Veterinary point of care diagnostics refers to rapid, near-patient testing performed in clinics, farms, shelters, equine facilities, and mobile veterinary settings to support timely clinical decisions for companion animals and livestock. The category includes immunoassays, hematology and clinical chemistry analyzers, molecular tests, urinalysis, blood gas and electrolyte systems, parasite screening, infectious disease testing, and emerging connected diagnostic platforms. Demand is being shaped by rising pet ownership, higher expectations for animal healthcare, increased awareness of zoonotic and foodborne diseases, and the need for faster treatment decisions in decentralized care environments. In companion animal medicine, point of care testing helps veterinarians evaluate acute illness, monitor chronic conditions, guide antimicrobial decisions, and improve client communication during a single visit. In livestock and production animal health, rapid diagnostics support herd management, biosecurity, outbreak containment, and responsible use of medicines. The veterinary diagnostics landscape is also being influenced by One Health priorities, as animal disease surveillance is increasingly linked with public health, food security, and antimicrobial resistance management. As practices seek faster turnaround times, improved diagnostic confidence, and workflow efficiency, veterinary point of care diagnostics is becoming a critical enabler of preventive care, precision treatment, and operational resilience across animal health systems.

Transformative Shifts Reshaping Veterinary Diagnostics

The veterinary point of care diagnostics landscape is undergoing transformative shifts driven by the convergence of digital connectivity, miniaturized instruments, molecular testing, and broader preventive care models. Veterinary practices are moving from reactive testing toward earlier disease detection, routine wellness screening, and longitudinal monitoring of chronic conditions such as kidney disease, endocrine disorders, inflammatory conditions, and infectious diseases. Portable analyzers and cartridge-based systems are reducing dependence on centralized laboratories for time-sensitive decisions, while cloud-connected platforms are improving record integration, quality control, and test result accessibility. In livestock health, rapid testing is becoming more important for farm-level biosecurity, reproductive management, respiratory disease control, mastitis screening, and surveillance of transboundary animal diseases. Regulatory and public health emphasis on antimicrobial stewardship is also increasing the value of diagnostics that help distinguish bacterial, viral, parasitic, and inflammatory causes of disease before treatment is initiated. At the same time, veterinary teams are facing staffing shortages and rising caseload complexity, making easy-to-use, automated, and low-maintenance diagnostic systems especially valuable. The strongest structural shift is the movement toward integrated diagnostic ecosystems that combine point of care testing, electronic medical records, telehealth support, and data-driven clinical decision-making.

Cumulative Impact of Artificial Intelligence on Veterinary Diagnostics

Artificial intelligence is creating a cumulative impact across veterinary point of care diagnostics by improving interpretation, workflow automation, image recognition, predictive analytics, and clinical decision support. AI-enabled diagnostic tools can support pattern recognition in cytology, hematology, urinalysis sediment analysis, radiology-adjacent workflows, and digital microscopy, helping veterinary professionals triage abnormal findings more consistently. In point of care environments, AI can reduce manual interpretation variability, flag quality-control issues, and assist clinicians in connecting test results with patient history, breed, age, clinical signs, and treatment response. Machine learning models are also being explored for early detection of disease patterns across animal populations, including herd-level health monitoring, outbreak signals, and antimicrobial resistance trends. The technology is particularly relevant where veterinary expertise is unevenly distributed, as AI-supported platforms can extend decision support to rural clinics, farm settings, shelters, and mobile units. However, adoption requires validated datasets, transparent algorithms, cybersecurity controls, regulatory clarity, and clinician oversight. The most practical near-term role of AI is not replacing veterinary judgment, but accelerating routine interpretation, improving consistency, strengthening surveillance, and enabling more proactive animal health management.

Key Regional Insights Across Veterinary Point of Care Diagnostics

Asia-Pacific is advancing rapidly as veterinary point of care diagnostics gains relevance across companion animal clinics, poultry and swine production, dairy operations, and aquaculture health programs. Urban pet ownership, expanding veterinary infrastructure, and government attention to animal disease surveillance are supporting adoption in China, India, Japan, South Korea, and Australia, while regional livestock density keeps infectious disease monitoring and farm-level testing central to public health and food security priorities. North America demonstrates mature clinical adoption, supported by a large companion animal healthcare base, advanced veterinary hospital networks, growing pet insurance penetration in selected settings, and strong interest in antimicrobial stewardship and chronic disease monitoring. Latin America is shaped by a dual demand profile, with growing companion animal care in urban centers and persistent need for livestock diagnostics in cattle, poultry, and swine systems, particularly where rapid testing supports export compliance, herd health, and zoonotic disease control. Europe emphasizes regulated animal health practices, food safety, animal welfare standards, and antimicrobial reduction policies, all of which strengthen the case for diagnostic-led treatment decisions in both clinics and production settings. The Middle East is seeing gradual adoption through premium companion animal care, equine medicine, falconry-related veterinary services, and investments in food security and livestock disease control. Africa presents an important need-based opportunity, as point of care testing can support surveillance of zoonotic diseases, livestock productivity, and rural veterinary access, although infrastructure gaps, affordability constraints, and supply chain consistency remain critical adoption barriers.

Key Group Insights Influencing Veterinary Diagnostic Adoption

ASEAN markets are characterized by a combination of rising urban pet care expenditure, expanding poultry and aquaculture industries, and heightened attention to transboundary animal diseases, making rapid, accessible diagnostics increasingly relevant for both clinic-based and field-based use. The GCC is developing demand through high-value companion animal services, equine and camel health, and national food security programs that require stronger livestock health monitoring and biosecurity capabilities. The European Union provides one of the most policy-driven environments for veterinary point of care diagnostics, with animal welfare rules, food safety systems, and antimicrobial resistance strategies encouraging evidence-based prescribing and systematic disease surveillance. BRICS countries represent diverse but significant diagnostic needs, ranging from large companion animal populations and expanding private veterinary care to intensive livestock systems that require cost-effective infectious disease detection and herd health management. G7 markets generally show advanced adoption conditions, including established veterinary infrastructure, higher acceptance of in-clinic testing, greater use of digital health records, and strong emphasis on preventive care. NATO countries, while not a healthcare market bloc, include many nations with advanced veterinary public health systems, defense-related animal health programs, and biosecurity priorities, reinforcing the importance of rapid diagnostics in outbreak preparedness, working animal health, and cross-border disease monitoring.

Key Country Insights Shaping Veterinary Point of Care Diagnostics

The United States remains a key adopter of veterinary point of care diagnostics due to its extensive companion animal care network, strong specialty and emergency veterinary services, and growing focus on preventive screening and chronic disease monitoring. Canada shows steady demand linked to companion animal care, livestock health, and antimicrobial stewardship, with regional needs spanning urban practices, dairy operations, and remote veterinary access. Mexico is influenced by expanding pet care services and livestock disease management requirements, particularly in cattle, poultry, and swine production. Brazil combines one of the world's major livestock sectors with rising companion animal healthcare expectations, making rapid diagnostics relevant for both farm productivity and urban clinic workflows. The United Kingdom emphasizes companion animal wellness, equine care, laboratory-quality clinical standards, and responsible antimicrobial prescribing, all supporting diagnostic-led veterinary decision-making. Germany benefits from advanced veterinary infrastructure, strong livestock production standards, and strict animal health oversight, while France shows demand across companion animal medicine, food animal health, and national surveillance frameworks. Russia's veterinary point of care needs are shaped by large geography, livestock production, and the value of decentralized testing in areas with limited laboratory access. Italy and Spain are supported by established small animal practices, livestock systems, and interest in infectious disease control, including vector-borne and parasitic conditions in warmer regions. China is expanding adoption through pet healthcare growth, modernization of veterinary services, and large-scale livestock and aquaculture disease management. India has substantial need for affordable, portable diagnostics across dairy, poultry, companion animals, and rural veterinary services. Japan demonstrates high standards in companion animal medicine and aging pet care, favoring diagnostics that support chronic disease management and rapid clinical decisions. Australia places strong emphasis on biosecurity, livestock health, equine medicine, companion animal care, and disease surveillance across geographically dispersed settings. South Korea is supported by rising pet ownership, advanced urban veterinary clinics, and increasing use of in-clinic diagnostic technologies.

Actionable Recommendations for Veterinary Diagnostic Leaders

Industry leaders should prioritize diagnostic platforms that deliver accuracy, speed, usability, and connectivity while fitting the real-world workflow of veterinary teams. Product strategies should focus on compact analyzers, multiplex testing, easy sample preparation, clear result interpretation, and integration with practice management systems. In companion animal care, leaders should align offerings with wellness testing, emergency triage, chronic disease monitoring, infectious disease panels, and client-facing communication tools that improve treatment acceptance. In livestock and field settings, emphasis should be placed on rugged portability, low maintenance, temperature-tolerant consumables, and cost-effective tests that support biosecurity, herd health, and antimicrobial stewardship. Commercial teams should adapt go-to-market models by region, recognizing that high-income urban clinics may prioritize advanced connectivity and broad test menus, while rural and production settings may prioritize affordability, durability, and training support. Evidence generation is essential; suppliers should invest in clinical validation, species-specific performance data, quality-control protocols, and education that helps veterinarians interpret results responsibly. Partnerships with veterinary schools, public health agencies, livestock organizations, shelters, and digital health providers can accelerate responsible adoption. Leaders should also prepare for AI-enabled diagnostics by strengthening data governance, cybersecurity, algorithm validation, and transparent clinical decision support frameworks.

Research Methodology for Veterinary Point of Care Diagnostic Analysis

This executive summary is developed through a structured secondary research approach focused on verified and data-backed industry evidence from animal health authorities, veterinary associations, peer-reviewed literature, regulatory sources, public health organizations, academic publications, and recognized government datasets. The methodology evaluates demand drivers across companion animal care, livestock health, zoonotic disease surveillance, antimicrobial stewardship, veterinary workforce trends, and diagnostic technology adoption. Regional, group, and country insights are assessed by examining veterinary infrastructure maturity, animal population dynamics, livestock production relevance, biosecurity priorities, pet healthcare trends, regulatory environments, and access to diagnostic services. The research framework emphasizes qualitative validation rather than market sizing or forecasting, ensuring that the analysis remains grounded in observed industry developments and documented healthcare needs. Technology trends are reviewed across immunodiagnostics, clinical chemistry, hematology, molecular diagnostics, digital microscopy, connected analyzers, and AI-supported interpretation. Insights are synthesized to identify practical implications for veterinary clinics, animal health providers, diagnostic developers, livestock stakeholders, and public health decision-makers. All conclusions are framed to support strategic planning without relying on speculative market estimates, share calculations, or forward-looking revenue projections.

Conclusion: Strategic Role of Veterinary Point of Care Diagnostics

Veterinary point of care diagnostics is becoming an essential component of modern animal healthcare as veterinarians, livestock producers, and public health stakeholders seek faster, more reliable, and more accessible diagnostic answers. The sector is being strengthened by preventive care trends, antimicrobial stewardship, zoonotic disease surveillance, chronic disease monitoring, and the modernization of veterinary workflows. Regional adoption varies according to veterinary infrastructure, animal health priorities, affordability, regulation, and biosecurity needs, but the underlying direction is consistent: rapid in-clinic and field-based diagnostics are moving closer to the center of clinical and population-level decision-making. Artificial intelligence, connectivity, and automation can improve diagnostic consistency and workflow efficiency when deployed with proper validation and veterinary oversight. For industry leaders, the most durable opportunities lie in clinically validated, user-friendly, connected, and context-specific solutions that support both companion animal medicine and production animal health. By aligning innovation with real-world veterinary needs, point of care diagnostics can improve treatment decisions, strengthen surveillance, reduce inappropriate antimicrobial use, and enhance animal welfare across global markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Point Of Care Diagnostics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments & Analyzers
  • 7.3. Consumables & Reagents
  • 7.4. Rapid Test Kits

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Companion Animals
    • 8.2.1. Cats
    • 8.2.2. Dogs
  • 8.3. Livestock
    • 8.3.1. Cattle
    • 8.3.2. Horses
    • 8.3.3. Poultry
    • 8.3.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Diagnostic Test Type

  • 9.1. Introduction
  • 9.2. Clinical Biochemistry
  • 9.3. Hematology
  • 9.4. Immunodiagnostics
  • 9.5. Molecular Diagnostics
  • 9.6. Urinalysis

10. Veterinary Point Of Care Diagnostics Market, by Technology

  • 10.1. Introduction
  • 10.2. ELISA
  • 10.3. Lateral Flow Assay
  • 10.4. PCR
  • 10.5. Microfluidics

11. Veterinary Point Of Care Diagnostics Market, by Sample Type

  • 11.1. Introduction
  • 11.2. Blood
  • 11.3. Feces
  • 11.4. Milk
  • 11.5. Saliva
  • 11.6. Urine

12. Veterinary Point Of Care Diagnostics Market, by Application

  • 12.1. Introduction
  • 12.2. Infectious Disease Testing
  • 12.3. Clinical Pathology
  • 12.4. Endocrinology
  • 12.5. Parasitology
  • 12.6. Metabolic Disorders

13. Veterinary Point Of Care Diagnostics Market, by End User

  • 13.1. Introduction
  • 13.2. Veterinary Hospitals & Clinics
  • 13.3. Veterinary Diagnostic Laboratories
  • 13.4. Research Institutes
  • 13.5. Livestock Farms & Facilities

14. Veterinary Point Of Care Diagnostics Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Veterinary Point Of Care Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Agrolabo Spa
  • 18.2. Antech Diagnostics, Inc. by Mars, Incorporated
  • 18.3. B. Braun SE
  • 18.4. Biogal Galed Labs
  • 18.5. BioMerieux SA
  • 18.6. BioNote, Inc.
  • 18.7. Chembio Diagnostic Systems, Inc. by Biosynex
  • 18.8. Dispomed Ltd.
  • 18.9. Esaote SpA
  • 18.10. Eurolyser Diagnostica GmbH
  • 18.11. Fassisi GmbH
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. Getein Biotech, Inc.
  • 18.14. IDEXX Laboratories, Inc.
  • 18.15. Medtronic PLC
  • 18.16. Mindray Medical International Limited
  • 18.17. Neogen Corporation
  • 18.18. Nova Biomedical Corporation
  • 18.19. Precision Biosensor Inc.
  • 18.20. QIAGEN N.V.
  • 18.21. Randox Laboratories Ltd.
  • 18.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 18.23. Thermo Fisher Scientific Inc.
  • 18.24. Vimian Group AB
  • 18.25. Virbac Corporation
  • 18.26. Woodley Equipment Company Inc.
  • 18.27. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RAPID TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RAPID TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RAPID TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL BIOCHEMISTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL BIOCHEMISTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL BIOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URINALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FECES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FECES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FECES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MILK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MILK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MILK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLINICAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CLINICAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARASITOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARASITOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARASITOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LIVESTOCK FARMS & FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL LIVESTOCK FARMS & FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL LIVESTOCK FARMS & FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 189. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 219. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 228. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 229. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. SPAIN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN VETERINARY POINT OF CARE DIAGNOSTICS